Literature DB >> 21543586

Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumonia.

Blanca E Gonzalez, Luis A Faverio, Francisco M Marty, Craig MacArthur, Robin B Churchill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21543586      PMCID： PMC3147327          DOI： 10.1128/CVI.00054-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  11 in total

1.  High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Authors:  Alessandra Mularoni; Elisa Furfaro; Maura Faraci; Alessia Franceschi; Paola Mezzano; Roberto Bandettini; Claudio Viscoli; Elio Castagnola
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

Review 2.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

3.  (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.

Authors:  Francisco M Marty; Sophia Koo; Julie Bryar; Lindsey R Baden
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

4.  [Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children].

Authors:  Li Zhao; Jing-Yan Tang; Ying Wang; Yun-Fang Zhou; Jing Chen; Bi-Ru Li; Hui-Lian Xue
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2009-11

5.  Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.

Authors:  Valerio Del Bono; Alessandra Mularoni; Elisa Furfaro; Emanuele Delfino; Lorenzo Rosasco; Franca Miletich; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

6.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

7.  Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction.

Authors:  Wang Jiancheng; Huang Minjun; An Yi-jun; Sun Lan; Guo Zengzhu; Su Jianrong; Kang Xixiong
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08       Impact factor: 2.803

8.  Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.

Authors:  P Brian Smith; Daniel K Benjamin; Barbara D Alexander; Melissa D Johnson; Malcolm A Finkelman; William J Steinbach
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

9.  Serum indicators for the diagnosis of pneumocystis pneumonia.

Authors:  Sadatomo Tasaka; Naoki Hasegawa; Seiki Kobayashi; Wakako Yamada; Tomoyasu Nishimura; Tsutomu Takeuchi; Akitoshi Ishizaka
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

10.  Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis.

Authors:  S J Levine; D Kennedy; J H Shelhamer; A Kovacs; I M Feuerstein; V J Gill; F Stock; D Solomon; C T Boylen; H Masur
Journal:  Am Rev Respir Dis       Date:  1992-10
View more
  1 in total

Review 1.  Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.

Authors:  Anna R Huppler; Brian T Fisher; Thomas Lehrnbecher; Thomas J Walsh; William J Steinbach
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.